Hayashi Y, Iwasaka T, Hachisuga T, Fukuda K, Tanaka T, Matsuo N, Sugimori H
Department of Obstetrics and Gynecology, Saga Medical School.
Nihon Sanka Fujinka Gakkai Zasshi. 1988 Jul;40(7):875-9.
The antiemetic efficacy of high-dose metoclopramide (MCP), diphenhydramine (DPH), methylprednisolone (MPL), and diazepam (DZP) was investigated in 40 gynecologic cancer patients for a total of 98 chemotherapy courses, treated with cisplatin (50 mg/m2). With MPL (500 mg i.v. x 2) plus DZP (5 mg i.m. x 2), no vomiting occurred in 0% and mild emesis (vomiting 1-2 times) occurred in 20% of 25 courses. With MCP (2 mg/kg i.v. x 5) plus DPH (40 mg i.v. x 3), no vomiting occurred in 35% and mild emesis occurred in 10% of 20 courses. With a combination of MCP plus DPH and MPL plus DZP, no vomiting occurred in 51% and mild emesis occurred in 25% of 53 courses. These results indicate that high-dose MCP plus DPH are effective in preventing cisplatin-induced vomiting. Furthermore, the antiemetic efficacy of MCP plus DPH (0-2 vomiting episodes: 45%) was significantly enhanced (p less than 0.05) by the combined use of MPL plus DZP (0-2 vomiting episodes: 76%).
在40例妇科癌症患者中,共进行了98个疗程的化疗,使用顺铂(50mg/m²),研究了大剂量甲氧氯普胺(MCP)、苯海拉明(DPH)、甲泼尼龙(MPL)和地西泮(DZP)的止吐效果。使用MPL(静脉注射500mg×2)加DZP(肌肉注射5mg×2)时,25个疗程中0%的患者未发生呕吐,20%的患者出现轻度呕吐(呕吐1 - 2次)。使用MCP(静脉注射2mg/kg×5)加DPH(静脉注射40mg×3)时,20个疗程中35%的患者未发生呕吐,10%的患者出现轻度呕吐。使用MCP加DPH与MPL加DZP联合用药时,53个疗程中51%的患者未发生呕吐,25%的患者出现轻度呕吐。这些结果表明,大剂量MCP加DPH对预防顺铂引起的呕吐有效。此外,联合使用MPL加DZP可显著增强MCP加DPH的止吐效果(0 - 2次呕吐发作:45%对0 - 2次呕吐发作:76%,p小于0.05)。